2-218663183-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM2PM5BP4

The NM_001079866.2(BCS1L):​c.1057G>T​(p.Val353Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V353M) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

BCS1L
NM_001079866.2 missense

Scores

6
13

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 7.66

Publications

0 publications found
Variant links:
Genes affected
BCS1L (HGNC:1020): (BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone) This gene encodes a homolog of the S. cerevisiae bcs1 protein which is involved in the assembly of complex III of the mitochondrial respiratory chain. The encoded protein does not contain a mitochondrial targeting sequence but experimental studies confirm that it is imported into mitochondria. Mutations in this gene are associated with mitochondrial complex III deficiency and the GRACILE syndrome. Several alternatively spliced transcripts encoding two different isoforms have been described. [provided by RefSeq, Jan 2016]
BCS1L Gene-Disease associations (from GenCC):
  • Bjornstad syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, Ambry Genetics, ClinGen, G2P
  • GRACILE syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • Leigh syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: PanelApp Australia, ClinGen
  • mitochondrial complex III deficiency nuclear type 1
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • mitochondrial complex III deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • renal tubulopathy-encephalopathy-liver failure syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr2-218663183-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 6166.
BP4
Computational evidence support a benign effect (MetaRNN=0.4048615).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BCS1LNM_001079866.2 linkc.1057G>T p.Val353Leu missense_variant Exon 8 of 8 ENST00000359273.8 NP_001073335.1 Q9Y276A0A024R445

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BCS1LENST00000359273.8 linkc.1057G>T p.Val353Leu missense_variant Exon 8 of 8 1 NM_001079866.2 ENSP00000352219.3 Q9Y276

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461894
Hom.:
0
Cov.:
33
AF XY:
0.00000275
AC XY:
2
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1112012
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Uncertain
0.089
D
BayesDel_noAF
Benign
-0.11
CADD
Benign
23
DANN
Benign
0.96
DEOGEN2
Uncertain
0.50
T;T;T;T;T;T;T
Eigen
Benign
-0.14
Eigen_PC
Benign
0.049
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.96
.;.;.;.;.;.;D
M_CAP
Benign
0.053
D
MetaRNN
Benign
0.40
T;T;T;T;T;T;T
MetaSVM
Benign
-0.46
T
MutationAssessor
Benign
0.53
N;N;N;N;N;N;N
PhyloP100
7.7
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-1.2
N;N;N;N;N;N;N
REVEL
Uncertain
0.35
Sift
Benign
0.50
T;T;T;T;T;T;T
Sift4G
Benign
0.44
T;T;T;T;T;T;T
Polyphen
0.0090
B;B;B;B;B;B;B
Vest4
0.51
MutPred
0.71
Gain of catalytic residue at V353 (P = 0.0491);Gain of catalytic residue at V353 (P = 0.0491);Gain of catalytic residue at V353 (P = 0.0491);Gain of catalytic residue at V353 (P = 0.0491);Gain of catalytic residue at V353 (P = 0.0491);Gain of catalytic residue at V353 (P = 0.0491);Gain of catalytic residue at V353 (P = 0.0491);
MVP
0.91
MPC
0.74
ClinPred
0.78
D
GERP RS
4.3
Varity_R
0.12
gMVP
0.71
Mutation Taster
=35/65
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121908574; hg19: chr2-219527906; API